Spots Global Cancer Trial Database for Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
Official Title: Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients : Clinical Trial, Cross-over Design, Double-blind, Placebo-control, Randomized, Single-center Study
Study ID: NCT06078605
Conditions
Study Description
Brief Summary: Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients : Clinical Trial, Cross-over Design, Double-blind, Placebo-control, Randomized, Single-center Study
Detailed Description: Not provided
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of
Contact Details
Name: Seungsoo Rho, MD, PhD
Affiliation: CHA Bundang Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
